Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|126|8|1944-1954

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.126, Iss.8, 2010-04, pp. : 1944-1954

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictive Role of ERCC1 Expression in Head and Neck Squamous Cell Carcinoma Patients Treated with Surgery and Adjuvant Cisplatin-Based Chemoradiation

By  

Oncology, Vol. 89, Iss. 4, 2015-06 ,pp. : 227-234

Karger

Access to resources Recommend Favorite

Endoglin promoter hypermethylation identifies a field defect in human primary esophageal cancer

By  

CANCER, Vol. 119, Iss. 20, 2013-10 ,pp. : 3604-3609

John Wiley & Sons Inc

Access to resources Recommend Favorite

p16 Promoter Hypermethylation in Human Hepatocellular Carcinoma with or without Hepatitis Virus Infection

By  

Intervirology, Vol. 47, Iss. 1, 2004-03 ,pp. : 26-31

Karger

Access to resources Recommend Favorite

Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer

By  

CANCER, Vol. 121, Iss. 9, 2015-05 ,pp. : 1395-1404

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reduced Expression of the TSP1 Gene and Its Association with Promoter Hypermethylation in Gastric Carcinoma

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 423-429

Karger

Access to resources Recommend Favorite